Indeed,higher Ki-67 expression in recurrent lesions compared to primary tumors suggestsmore aggressive tumor behavior and may influence treatment approaches, such aschemotherapy or targeted therapies [92]. The gene discussed is MKI67; the disease is neoplasm.